Department of Experimental, Diagnostic and Specialty Medicine (DIMES), General Pathology Building, University of Bologna, 40126 Bologna, Italy.
Int J Mol Sci. 2018 Feb 15;19(2):580. doi: 10.3390/ijms19020580.
Glycosylation is a very frequent and functionally important post-translational protein modification that undergoes profound changes in cancer. Growth and death factor receptors and plasma membrane glycoproteins, which upon activation by extracellular ligands trigger a signal transduction cascade, are targets of several molecular anti-cancer drugs. In this review, we provide a thorough picture of the mechanisms bywhich glycosylation affects the activity of growth and death factor receptors in normal and pathological conditions. Glycosylation affects receptor activity through three non-mutually exclusive basic mechanisms: (1) by directly regulating intracellular transport, ligand binding, oligomerization and signaling of receptors; (2) through the binding of receptor carbohydrate structures to galectins, forming a lattice thatregulates receptor turnover on the plasma membrane; and (3) by receptor interaction with gangliosides inside membrane microdomains. Some carbohydrate chains, for example core fucose and β1,6-branching, exert a stimulatory effect on all receptors, while other structures exert opposite effects on different receptors or in different cellular contexts. In light of the crucial role played by glycosylation in the regulation of receptor activity, the development of next-generation drugs targeting glyco-epitopes of growth factor receptors should be considered a therapeutically interesting goal.
糖基化是一种非常普遍且在功能上非常重要的翻译后蛋白质修饰,它在癌症中发生深刻变化。生长因子受体和质膜糖蛋白在受到细胞外配体激活后会触发信号转导级联反应,是几种分子抗癌药物的作用靶点。在这篇综述中,我们全面描述了糖基化如何在正常和病理条件下影响生长因子受体活性的机制。糖基化通过三种非相互排斥的基本机制影响受体活性:(1)通过直接调节受体的细胞内运输、配体结合、寡聚化和信号转导;(2)通过受体碳水化合物结构与半乳糖凝集素的结合,形成调节质膜上受体周转率的晶格;(3)通过受体与膜微域内神经节苷脂的相互作用。一些碳水化合物链,例如核心岩藻糖和β1,6-分支,对所有受体都有刺激作用,而其他结构对不同受体或在不同细胞环境中则产生相反的作用。鉴于糖基化在调节受体活性中发挥的关键作用,开发针对生长因子受体糖基化表位的下一代药物应被视为一个具有治疗意义的目标。